Gene polymorphisms of interleukin-10 and transforming growth factor beta in allergic rhinitis
For many individuals using GLP-1 medications, that apprehension turns into a physical reality when nausea begins to interfere with daily life
Men's skin is about 2025% thicker than women's on average, which means it holds collagen and elastin structure differently as it ages
What's Next: Orforglipron (oral GLP-1) completing Phase 3 trials with submissions expected by year-end 2025 CEO Dave Ricks expects FDA approval by March 2026 International launches accelerating in China, Brazil, India, and Mexico The GLP-1 market is projected to exceed $100B+ by the early 2030s, and Lilly is positioned as the category leader
To view a copy of this license, visit About this article Cite this article Polacchini, A., Metelli, G., Francavilla, R